Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial
- DOI
- 10.1016/s1474-4422(24)00447-2
- Published
- 2025-01
- Container
- The Lancet Neurology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-24-00447-2,
title = {Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial},
author = {Norbert Weidner and Rainer Abel and Doris Maier and Klaus Röhl and Frank Röhrich and Michael Baumberger and Margret Hund-Georgiadis and Marion Saur and Jesús Benito-Penalva and Kerstin Rehahn and Mirko Aach and Andreas Badke and Jiri Kriz and Katalin Barkovits and Tim Killeen and Lynn Farner and Maryam Seif and Michèle Hubli and Katrin Marcus and Michael A Maurer and Bérénice Robert and Rüdiger Rupp and Paulina S Scheuren and Martin Schubert and Christian Schuld and Christina Sina and Bettina Steiner and Tanja Weis and Andreas Hug and Marc Bolliger and Nikolaus Weiskopf and Patrick Freund and Torsten Hothorn and Martin E Schwab and Armin Curt},
year = {2025},
journal = {The Lancet Neurology},
doi = {10.1016/s1474-4422(24)00447-2},
url = {https://doi.org/10.1016/s1474-4422(24)00447-2}
}RIS
TY - JOUR TI - Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial AU - Norbert Weidner AU - Rainer Abel AU - Doris Maier AU - Klaus Röhl AU - Frank Röhrich AU - Michael Baumberger AU - Margret Hund-Georgiadis AU - Marion Saur AU - Jesús Benito-Penalva AU - Kerstin Rehahn AU - Mirko Aach AU - Andreas Badke AU - Jiri Kriz AU - Katalin Barkovits AU - Tim Killeen AU - Lynn Farner AU - Maryam Seif AU - Michèle Hubli AU - Katrin Marcus AU - Michael A Maurer AU - Bérénice Robert AU - Rüdiger Rupp AU - Paulina S Scheuren AU - Martin Schubert AU - Christian Schuld AU - Christina Sina AU - Bettina Steiner AU - Tanja Weis AU - Andreas Hug AU - Marc Bolliger AU - Nikolaus Weiskopf AU - Patrick Freund AU - Torsten Hothorn AU - Martin E Schwab AU - Armin Curt PY - 2025 JO - The Lancet Neurology DO - 10.1016/s1474-4422(24)00447-2 UR - https://doi.org/10.1016/s1474-4422(24)00447-2 ER -
APA
Weidner, N., Abel, R., Maier, D., Röhl, K., Röhrich, F., Baumberger, M., Hund-Georgiadis, M., Saur, M., Benito-Penalva, J., Rehahn, K., Aach, M., Badke, A., Kriz, J., Barkovits, K., Killeen, T., Farner, L., Seif, M., Hubli, M., Marcus, K., Maurer, M. A., Robert, B., Rupp, R., Scheuren, P. S., Schubert, M., Schuld, C., Sina, C., Steiner, B., Weis, T., Hug, A., Bolliger, M., Weiskopf, N., Freund, P., Hothorn, T., Schwab, M. E., & Curt, A. (2025). Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(24)00447-2
Source records
- crossref · retrieved 2026-09-26T05:04:35.000Z